SCHEMBL1876220

SCHEMBL1876220

COC(=O)C(C)NC(C)=O

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 1/20 0.50
TSHR P16473 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.41
RECQL P46063 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.39
BIRC2 Q13490 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805648 1.00 CA14 (0.50) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL1884920 1.00 CA14 (0.50) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL20393857 0.91 CA14 (0.43) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL21738188 0.91 CA14 (0.43) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL13645819 0.91 CA14 (0.43) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL7776379 0.91 CA14 (0.43) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL11664935 0.81 CA14 (0.52) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL30493714 0.81 MEN1 (0.44) CA14TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL5808282 0.80 TSHR (0.46) CA14TSHRSMN1; SMN2MAPTGAA
SCHEMBL21488518 0.80 GAA (0.39) CA14TSHRMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105693541-B A kind of synthetic method of ethyldopa 湖南湘易康制药有限公司 2017-12-22 CN claimed
CN-105693541-A Synthetic method of methyldopa 湖南湘易康制药有限公司 2016-06-22 CN claimed
WO-2006119283-A2 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J (US) 2006-11-09 WO claimed
US-20060251597-A1 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J 2006-11-09 US claimed
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS THE WILLIAM M YARBROUGH FOUNDATION 2023-10-26 US disclosed
WO-2023181844-A1 VIRAL INFECTION INHIBITOR, VIRAL INFECTION INHIBITING MEMBER, AND VIRAL INFECTION INHIBITING PAINT 積水化学工業株式会社 2023-09-28 WO disclosed
US-20210179553-A1 HYDROPERSULFIDE PRECURSORS NATIONAL SCIENCE FOUNDATION 2021-06-17 US disclosed
US-10793670-B2 Synthesis of tyrosine derived polyarylates MEDTRONIC, INC. (US) 2020-10-06 US disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
WO-2020047359-A1 HYDROPERSULFIDE PRECURSORS THE JOHNS HOPKINS UNIVERSITY (US) 2020-03-05 WO disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2018-08-02 US disclosed
US-5371256-A With rhodium and iridium CIBA-GEIGY CORPORATION (US) 1994-12-06 US disclosed
CN-1075967-A Fungicidal silicon-containing compounds, method for the production thereof and their use in agrochemical and pharmaceutical applications SANKYO CO (JP) 1993-09-08 CN disclosed
EP-0498507-A1 Process for the preparation of enantiomers of alpha-amino acid derivatives by asymmetric hydrogenation DSM N.V. (NL) 1992-08-12 EP disclosed
EP-0145265-B1 ALPHA-AMINO ACIDS THROUGH CATALYTIC REACTION OF CO AND A HYDROXYL COMPOUND WITH ENAMIDES THE STANDARD OIL COMPANY (US) 1989-09-20 EP disclosed
US-4749786-A α-amino acids through catalytic reaction of CO and a hydroxyl compound with enamides THE STANDARD OIL COMPANY (US) 1988-06-07 US disclosed
US-4710574-A HYDROCARBOXYLATION OF UNSATURATED AMIDES THE STANDARD OIL COMPANY (US) 1987-12-01 US disclosed
EP-0145265-A2 Alpha-amino acids through catalytic reaction of CO and a hydroxyl compound with enamides THE STANDARD OIL COMPANY (US) 1985-06-19 EP disclosed
US-RE29843-E Substituted thiazoles and flavoring processes and products produced thereby INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1978-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, MRPS18A CA14 642/4885TSHR 2869/4885MEN1 1772/4885
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof MRPL38, ALG8, COG8 CA14 923/4885TSHR 3054/4885MEN1 1107/4885
US-20180214561-A1 EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF MRPL38, CXCL8, ALG8 CA14 715/4885TSHR 2426/4885MEN1 2488/4885
US-20210179553-A1 HYDROPERSULFIDE PRECURSORS GPX4, SQOR, GPX1 CA14 3202/4885TSHR 3021/4885MEN1 2876/4885
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS MIF, TNF, MMP12 CA14 423/4885TSHR 1323/4885MEN1 1232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.